Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1599 results found

2024 ∙ Raji, T. Fallah, M. P. Dereje, N. Kakooza, F. Ndembi, N. Abdulaziz, M. Aragaw, M. Kaseya, J. Ngongo, A. N.

Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review

  • Africa
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Jain, H. Odat, R. M. Hussein, A. M. Dey, D. Ahmed, M. Jain, J. Goyal, A. Ratnani, T. Idrees, M. Prajjwal, P. Passey, S. Yadav, R.

Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Rayner, D. G. Nunes, J. T. Gou, D. Chu, A. W. L. Dai, S. C. Sheikh, A. Meng, D. Orchanian-Cheff, A. Oss, S. Rotstein, C. Aleksova, N. Foroutan, F.

Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: A systematic review and network meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Choi, S. H. Yu, S. Y. Kim, J. Choi, M. Choi, Y. Y. Choi, J. H. Yun, K. W. Choe, Y. J.

Efficacy and Safety of COVID-19 Vaccines in Adolescents: Systematic Review of Randomized Controlled Studies and Observational Studies

  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Cheng, M. Q. Weng, Z. Y. Li, R. Song, G.

Efficacy of adjuvant-associated COVID-19 vaccines against SARS-CoV-2 variants of concern in randomized controlled trials: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Das Barshan, A. Matsumoto-Takahashi, E. L. A.

Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Rubin, M. Suelzer, E. Ulschmid, C. Thapa, B. Szabo, A. Abid, M. B.

Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Germana-Emerita, V. Gregorio Angelo-Martin, B. Catacutan Ma.-Lucila, M. Perez Leonila, F. Dans

Efficacy, effectiveness, and safety of COVID-19 vaccine compared to placebo in preventing COVID-19 infection among 12-17 years old: A systematic review

  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Muchangi, J. M. Mturi, J. Mukasa, H. Kithuki, K. Kosgei, S. J. Kanyangi, L. M. Moraro, R. Nankanja, M.

Enablers and barriers to vaccine uptake and handwashing practices to prevent and control COVID-19 in Kenya, Uganda, and Tanzania: a systematic review

  • Africa
  • Kenya
  • Uganda
  • All age groups
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Hashan, M. R. Smoll, N. Chapman, G. King, C. Walker, J. Kirk, M. Akbar, D. Booy, R. Khandaker, G.

Epidemiology of COVID-19 outbreaks in aged care facilities during postvaccine period: a systematic review and meta-analysis

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...